These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29404152)

  • 1. The Effect of Working in a Smoke-Free Workplace on use of Smoking and Smokeless Tobacco.
    Kahraman H; Sucaklı MH; Atilla N; Arpağ H; Bozkuş F; Köksal N
    Turk Thorac J; 2017 Jan; 18(1):14-18. PubMed ID: 29404152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary cotinine levels of smokeless tobacco (Maraş powder) users.
    Cok I; Oztürk R
    Hum Exp Toxicol; 2000 Nov; 19(11):650-5. PubMed ID: 11211244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum total sialic acid levels in smokers and users of smokeless tobacco in form of oral powder (Maraş powder).
    Kurtul N; Cil MY; Paçaci SD
    J Biomed Sci; 2005; 12(3):559-63. PubMed ID: 15959629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of adult attention deficit hyperactivity disorder in smokers and Maras powder users.
    Keten HS; Onay H; Ersoy O; Isik O; Gencoglan S; Ucer H; Celik M
    Nord J Psychiatry; 2015; 69(7):557-62. PubMed ID: 25762109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Maras powder use on patients with migraine.
    İnanç Y; Orhan FÖ; İnanç Y
    Neuropsychiatr Dis Treat; 2018; 14():1143-1148. PubMed ID: 29765218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of smokeless tobacco "Maras powder" use on nitric oxide and cardiovascular risk parameters.
    Guven A; Tolun F
    Int J Med Sci; 2012; 9(9):786-92. PubMed ID: 23136542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of knowledge and behavior of and attitudes towards smoking cigarettes and using smokeless tobacco in patients with chronic renal failure.
    Sucakli MH; Kahraman H; Altunoren O; Celik M; Sayarlioglu H; Dogan E
    Transplant Proc; 2013; 45(6):2129-32. PubMed ID: 23953522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Candida carriage and prevalence of Candida species among Maras powder users and non-users.
    Keten D; Keten HS; Goktas MT; Ucer H; Ersoy O; Celik M
    J Oral Pathol Med; 2015 Aug; 44(7):502-6. PubMed ID: 25213478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Maras powder affect the nasal mucociliary clearence?
    Kara İ; Cınar OF; Doğaner A; Yıldız MG; Sağıroğlu S; Bilal N; Orhan I
    Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5701-5706. PubMed ID: 35748933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of smokeless tobacco "Maras powder" use on respiratory functions.
    Buyukbese MA; Koksal N; Guven A; Cetinkaya A
    Tohoku J Exp Med; 2004 Nov; 204(3):173-8. PubMed ID: 15502415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of smokeless tobacco (Maras powder) use on carotid intima media thickness.
    Sucakli MH; Ozkan F; Inci MF; Celik M; Keten HS; Bozoglan O
    Med Sci Monit; 2013 Oct; 19():859-64. PubMed ID: 24129168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of using a different kind of smokeless tobacco on cardiac parameters: "Maraş Powder".
    Güven A; Köksal N; Büyükbeşe MA; Cetinkaya A; Sökmen G; Aksu E; Cağlayan CE
    Anadolu Kardiyol Derg; 2003 Sep; 3(3):230-5. PubMed ID: 12967890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Maras powder and smoking on the microRNA deregulation of oral mucosa.
    Taş B; Güre AO
    J Appl Oral Sci; 2020; 28():e20190382. PubMed ID: 32049136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of genotoxic damage in smokeless tobacco ((Maraş powder) consumers using micronucleated exfoliated oral cells.
    Burgaz S; Ok I; Uysal BT; Karakaya AE
    Biomarkers; 2000; 5(3):219-24. PubMed ID: 23889223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of micronuclei by smokeless tobacco on buccal mucosa cells of habitual users.
    Ozkul Y; Donmez H; Erenmemisoglu A; Demirtas H; Imamoglu N
    Mutagenesis; 1997 Jul; 12(4):285-7. PubMed ID: 9237775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging evaluation of the effects of cigarette and maras powder (smokeless tobacco) on lumbar disc degeneration.
    Doğan A; Doğan K; Taşolar S
    Clin Neurol Neurosurg; 2019 Nov; 186():105500. PubMed ID: 31557568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binary classification of users of electronic cigarettes and smokeless tobacco through biomarkers to assess similarity with current and former smokers: machine learning applied to the population assessment of tobacco and health study.
    Ohara H; Ito S; Takanami Y
    BMC Public Health; 2023 Mar; 23(1):589. PubMed ID: 36991369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of smoke-free law on tobacco consumption in Chandigarh: a community-based study.
    Chavan BS; Sidana A; Kaushal T
    Indian J Med Sci; 2010 Mar; 64(3):125-31. PubMed ID: 22569325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between active smoking, smokeless tobacco, second-hand smoke exposure and insufficient sleep.
    Sabanayagam C; Shankar A
    Sleep Med; 2011 Jan; 12(1):7-11. PubMed ID: 21144798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users.
    Sagiroglu S; Erdogan A; Doganer A; Okyay RA
    North Clin Istanb; 2019; 6(3):284-292. PubMed ID: 31650117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.